atai Life Sciences (ATAI) Competitors $5.49 -0.12 (-2.14%) Closing price 09/24/2025 04:00 PM EasternExtended Trading$5.27 -0.22 (-4.01%) As of 08:56 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ATAI vs. ACAD, PTGX, ADMA, MIRM, AKRO, ZLAB, KYMR, AAPG, MLTX, and LNTHShould you be buying atai Life Sciences stock or one of its competitors? The main competitors of atai Life Sciences include ACADIA Pharmaceuticals (ACAD), Protagonist Therapeutics (PTGX), ADMA Biologics (ADMA), Mirum Pharmaceuticals (MIRM), Akero Therapeutics (AKRO), Zai Lab (ZLAB), Kymera Therapeutics (KYMR), Ascentage Pharma Group International (AAPG), MoonLake Immunotherapeutics (MLTX), and Lantheus (LNTH). These companies are all part of the "pharmaceutical products" industry. atai Life Sciences vs. Its Competitors ACADIA Pharmaceuticals Protagonist Therapeutics ADMA Biologics Mirum Pharmaceuticals Akero Therapeutics Zai Lab Kymera Therapeutics Ascentage Pharma Group International MoonLake Immunotherapeutics Lantheus atai Life Sciences (NASDAQ:ATAI) and ACADIA Pharmaceuticals (NASDAQ:ACAD) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment and earnings. Is ATAI or ACAD more profitable? ACADIA Pharmaceuticals has a net margin of 21.80% compared to atai Life Sciences' net margin of 0.00%. ACADIA Pharmaceuticals' return on equity of 14.69% beat atai Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets atai Life SciencesN/A -85.43% -64.38% ACADIA Pharmaceuticals 21.80%14.69%9.41% Do analysts prefer ATAI or ACAD? atai Life Sciences currently has a consensus target price of $11.25, indicating a potential upside of 104.92%. ACADIA Pharmaceuticals has a consensus target price of $29.53, indicating a potential upside of 38.90%. Given atai Life Sciences' stronger consensus rating and higher probable upside, equities analysts plainly believe atai Life Sciences is more favorable than ACADIA Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score atai Life Sciences 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.17ACADIA Pharmaceuticals 1 Sell rating(s) 6 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 2.65 Do institutionals and insiders have more ownership in ATAI or ACAD? 28.4% of atai Life Sciences shares are held by institutional investors. Comparatively, 96.7% of ACADIA Pharmaceuticals shares are held by institutional investors. 26.8% of atai Life Sciences shares are held by insiders. Comparatively, 26.5% of ACADIA Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has more volatility & risk, ATAI or ACAD? atai Life Sciences has a beta of 1.55, suggesting that its share price is 55% more volatile than the S&P 500. Comparatively, ACADIA Pharmaceuticals has a beta of 0.75, suggesting that its share price is 25% less volatile than the S&P 500. Which has preferable valuation and earnings, ATAI or ACAD? ACADIA Pharmaceuticals has higher revenue and earnings than atai Life Sciences. atai Life Sciences is trading at a lower price-to-earnings ratio than ACADIA Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratioatai Life Sciences$310K3,795.89-$149.27M-$0.69-7.96ACADIA Pharmaceuticals$1.02B3.52$226.45M$1.3315.98 Does the media favor ATAI or ACAD? In the previous week, ACADIA Pharmaceuticals had 12 more articles in the media than atai Life Sciences. MarketBeat recorded 25 mentions for ACADIA Pharmaceuticals and 13 mentions for atai Life Sciences. ACADIA Pharmaceuticals' average media sentiment score of 0.51 beat atai Life Sciences' score of 0.50 indicating that ACADIA Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment atai Life Sciences 5 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral ACADIA Pharmaceuticals 7 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 6 Negative mention(s) 3 Very Negative mention(s) Positive SummaryACADIA Pharmaceuticals beats atai Life Sciences on 11 of the 17 factors compared between the two stocks. Get atai Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATAI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ATAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ATAI vs. The Competition Export to ExcelMetricatai Life SciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.20B$5.57B$5.77B$10.41BDividend YieldN/A1.28%5.68%4.62%P/E Ratio-7.9628.1476.0426.42Price / Sales3,795.89202.08521.33168.33Price / CashN/A27.7637.5661.52Price / Book7.964.7612.876.39Net Income-$149.27M$197.51M$3.29B$271.13M7 Day Performance16.31%1.18%0.80%0.93%1 Month Performance15.82%2.13%4.91%7.52%1 Year Performance365.25%21.58%67.75%30.06% atai Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ATAIatai Life Sciences3.2609 of 5 stars$5.49-2.1%$11.25+104.9%+365.3%$1.20B$310K-7.9680Analyst ForecastGap UpHigh Trading VolumeACADACADIA Pharmaceuticals4.3631 of 5 stars$24.53+0.5%$29.65+20.9%+34.2%$4.14B$957.80M18.44510Trending NewsAnalyst ForecastOptions VolumeGap DownPTGXProtagonist Therapeutics1.6307 of 5 stars$64.51+3.7%$68.08+5.5%+41.6%$4.01B$209.18M92.16120Insider TradeADMAADMA Biologics3.2954 of 5 stars$16.03+0.8%$27.67+72.6%-18.8%$3.83B$426.45M18.64530Positive NewsMIRMMirum Pharmaceuticals3.4329 of 5 stars$73.93-0.6%$74.44+0.7%+90.5%$3.71B$429.16M-61.10140Analyst ForecastHigh Trading VolumeAKROAkero Therapeutics3.9879 of 5 stars$46.41+2.6%$81.14+74.8%+69.2%$3.71BN/A-23.2130Positive NewsZLABZai Lab3.0985 of 5 stars$33.15+1.5%$56.35+70.0%+50.6%$3.70B$398.99M-16.251,869KYMRKymera Therapeutics1.8782 of 5 stars$51.00+3.8%$59.95+17.6%+0.2%$3.65B$44.71M-14.70170Analyst RevisionAAPGAscentage Pharma Group InternationalN/A$38.31-1.4%N/AN/A$3.57B$134.35M0.00600Gap DownMLTXMoonLake Immunotherapeutics2.4894 of 5 stars$54.98+2.2%$74.43+35.4%-0.6%$3.53BN/A-19.782Positive NewsLNTHLantheus4.5336 of 5 stars$50.11-0.6%$85.50+70.6%-52.4%$3.41B$1.53B13.33700Trending News Related Companies and Tools Related Companies ACAD Competitors PTGX Competitors ADMA Competitors MIRM Competitors AKRO Competitors ZLAB Competitors KYMR Competitors AAPG Competitors MLTX Competitors LNTH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ATAI) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding atai Life Sciences N.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share atai Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATAI Stock Alerts